Clinical selection criteria in new clinical trials of hidradenitis suppurativa: External validity and implications on the daily clinical practice-Reference-Cited by-同舟云学术

Clinical selection criteria in new clinical trials of hidradenitis suppurativa: External validity and implications on the daily clinical practice

Published:2020-09-15 Issue:6 Volume:33 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Montero‐Vilchez Trinidad¹²^ORCID,Salvador‐Rodriguez Luis¹²,Sanchez‐Diaz Manuel¹²,Cuenca‐Barrales Carlos¹²^ORCID,Martinez‐Lopez Antonio¹²^ORCID,Arias‐Santiago Salvador¹²³,Molina‐Leyva Alejandro¹²⁴^ORCID

Affiliation:

1. Department of Dermatology, Hidradenitis Suppurativa Clinic Hospital Universitario Virgen de las Nieves Granada Spain

2. Instituto de Investigación Biosanitaria Granada Granada Spain

3. Department of Medicine, Granada School of Medicine, Granada University Granada Spain

4. European Hidradenitis Suppurativa Foundation Dessau‐Roßlau Germany

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.14254

Reference42 articles.

1. Hidradenitis Suppurativa

2. Hidradenitis suppurativa: A comprehensive review

3. Prevalence and factors associated with hidradenitis suppurativa: Results from two case-control studies

4. Epidemiology of hidradenitis suppurativa in Germany – an observational cohort study based on a multisource approach

5. The prevalence of hidradenitis suppurativa and its potential precursor lesions

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eligibility in a cohort of patients with hidradenitis suppurativa treated with bimekizumab: Lessons and pitfalls in a real‐world setting;Journal of the European Academy of Dermatology and Venereology;2024-02-27

2. Real-world safety and clinical response of Janus kinase inhibitor upadacitinib in the treatment of hidradenitis suppurativa: A retrospective cohort study;Journal of the American Academy of Dermatology;2022-12

3. Switching from Adalimumab Originator to Biosimilar: Clinical Experience in Patients with Hidradenitis Suppurativa;Journal of Clinical Medicine;2022-02-15

4. Potential Benefits of the Mediterranean Diet and Physical Activity in Patients with Hidradenitis Suppurativa: A Cross-Sectional Study in a Spanish Population;Nutrients;2022-01-27

5. The Role of Oral Contraceptive Pills in Hidradenitis Suppurativa: A Cohort Study;Life;2021-07-15